Invenomic Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Invenomic Capital Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-209,175	Closed	-$828K	–	175
2022 Q3	$828K	Sell	209,175 -848,671	-80%	-$5.22M	0.07%	144
2022 Q2	$5.86M	Sell	1,057,846 -25,775	-2%	-$211K	0.42%	70
2022 Q1	$12.7M	Buy	1,083,621 +832,835	+332%	+$11.1M	1.35%	15
2021 Q4	$3.96M	Buy	+250,786	New	+$6.02M	0.85%	43

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invenomic Capital Management's DMTK Position: Q4 2022 in Review

Invenomic Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 209,175 shares — an estimated $828K sold.

Invenomic Capital Management first reported a position in DMTK in Q4 2021 and held it in 4 quarters. The position peaked at $12.7M in Q1 2022. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

Invenomic Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Invenomic Capital Management sold 209,175 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $828K.
Invenomic Capital Management first reported a position in DermTech, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Invenomic Capital Management's DermTech, Inc. Common Stock position peaked at $12.7M in Q1 2022.
94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Invenomic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.